Reaching A1c Goals: Research Says These Factors Matter Most
Your HbA1c (A1c) is one part of your toolkit as a person with type 1 diabetes (T1D). This number cannot…
FDA Approves First Drug to Delay the Full Onset of Type 1 Diabetes
The FDA approval of teplizumab — brand name Tzield — was announced today on November 17, 2022 for use in people…
Where to Find T1D Exchange at ADA’s 81st Scientific Sessions
The American Diabetes Association’s (ADA) 81st Scientific Sessions are right around the corner, and T1D Exchange is thrilled to be among the many…
Weekly Coronavirus Resources for People with T1D – 9/20/2020
Everything you need to know this week about type 1 diabetes, in one easy-to-read place! Researchers, advocates, clinicians, and organizations…
Closed-Loop Study with Tandem “Artificial Pancreas” Showed Promising Results in Children
A 16-week, multi-center, randomized trial of over 100 children aged 6 to 13 at sites around the U.S. showed improved…
Why Diversity is Important in Research
Diversity: The differences in age, race, gender, ethnicity, education, and background within a group – is a critical but often-neglected aspect of research and scientific inquiry. We frequently hear about its importance in many aspects of our life, such as schools and the workplace. However, diversity is particularly important when studying diseases and chronic conditions.
T1D Exchange to Present Ten Studies Focused on Quality Improvement, Population Health and Real-World Evidence in Type 1 Diabetes at 80th American Diabetes Association Scientific Sessions
BOSTON–(BUSINESS WIRE)–T1D Exchange today announced that it will share data from ten abstracts, including six late breaking, focused on quality improvement, population health and real-world evidence and outcomes of people living with type 1 diabetes (T1D) at the American Diabetes Association (ADA) 80th Scientific Virtual Sessions. Two posters from the organization’s Quality Improvement Collaborative were recognized by healthcare information firm Close Concerns in its list of Top 50 Most Notable Posters.
Preliminary Findings of T1D Exchange’s Population Health Surveillance Study of COVID-19 in Individuals with Type 1 Diabetes Published in Diabetes Care
Preliminary results of our population health surveillance study, “Type 1 Diabetes and COVID-19: Preliminary Findings from a Multi-Center Surveillance Study in the United States,” were recently published in Diabetes Care, the peer-reviewed medical journal of the American Diabetes Association. The study focuses on individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). This is the first U.S. based, multi-center study to examine patient characteristics and adverse outcomes among individuals with confirmed or suspected COVID-19.
Why are T1Ds Dying at Higher Rates from COVID-19 than T2Ds? Poor Hospital Care May be to Blame
A new study recently released by the National Health Service in the United Kingdom showed that people with type 1 diabetes are significantly more likely to die in the hospital setting from COVID-19 than people living with type 2 diabetes.
Weekly Coronavirus Resources for People with T1D – 5/22/2020
We’re going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.
